NYSE, TGX - Theragenics Corp.
Theragenics Corporation? (the ?Company?) is a medical device company serving the
cancer treatment and surgical markets, operating in two business segments.
In its brachytherapy seed business, the Company produces, markets and sells
TheraSeed?, its premier palladium-103 prostate cancer treatment device; I-Seed,
its iodine-125 based prostate cancer treatment device; and other related
products and services. Theragenics is the world?s largest producer of
palladium-103, the radioactive isotope that supplies the therapeutic radiation
for its TheraSeed? device. Physicians, hospitals and other healthcare providers,
primarily located in the United States, utilize the TheraSeed? device. The
majority of TheraSeed? sales are channeled through one third-party distributor.
The Company also maintains an in-house sales force and sells its TheraSeed? and
I-Seed devices directly to physicians. ...
Read SEC Filing on NASDAQ.com »